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Abstract
Background: To find out about the prenatal diagnosis rate of myelomeningocele (MMC) by
ultrasound scan in patients referred to the Children's Hospital Medical Center in Tehran, Iran from
July 2004 to July 2005.
Methods: We included 140 children born with MMC and who were referred for management,
surgery and treatment of complications associated with it. The ultrasound reports were examined.
Data on sex, age, location of MMC, time of prenatal ultrasound and the trimester in which the
diagnosis was made along with the results of the diagnosis (MMC, hydrocephalus, or both), were
collected.
Results: Among the studied patients, 136 (97.1%) cases had prenatal ultrasound, amongst those,
58 (42.6%) sonographic evaluations were diagnostic for hydrocephalus and/or MMC. The prenatal
ultrasound was positive for MMC in 16 (11.8%), hydrocephalus in 25 (18.4%) and both MMC and
hydrocephalus in 17 (12.5%) cases. Among all cases with prenatal diagnosis of MMC, 3.4% were
detected in the first, 31% in the second and 65.5% in the third trimester. Thoracic/thoracolumbar
lesions were found prenatally in 40% of cases, which is significantly higher than the detection rate
of other locations including cervical/cervicothoracic and lumbar/lumbosacral/sacral regions
diagnosed only in 0% and 21% of cases respectively.
Conclusion: There is a large difference between the detection rate of our population (24.3%)
compared to others (68%). Pregnant women should have an ultrasound at 20–22 week for
detection of congenital anomalies including MMC.
Background
Myelomeningocele is a major congenital anomaly caused
by a defective closure of the neural tube between the 18–
25th days of gestation, resulting in the protrusion of the
cord and the meninges through the defective bony encase-
ment of the spinal column [1]. It is a prevalent and crip-
pling defect of the central nervous system (CNS) for which
no definitive cure is available. Patients born with MMC
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have lifelong disabilities including motory, sensory,
orthopedic and urologic problems. In spite of being a
common birth defect with significant lifelong complica-
tions, little progress has been made in the postnatal surgi-
cal management of the defects or its associated
complications.
During the past decades new screening methods and diag-
nostic tests have been introduced, allowing an earlier and
more accurate diagnosis of fetal anomalies, including
MMC [2]. As no definite treatment is available for MMC,
the prenatal detection of this handicapping anomaly
would help in the timely pregnancy termination as done
in developed countries [3]. Studies have shown that the
incidence of this malformation is relatively high in Iran,
1.6 per 1000 live births [4], and our experience with MMC
patients revealed that most of them were not detected pre-
natally. Early detection of abnormalities is helpful in mak-
ing decisions earlier in pregnancy. We retrospectively
studied the prenatal ultrasound scan detection rate in
patients with MMC referred to our center.
Methods
The study comprised of 140 patients referred for MMC
evaluation, surgery and management of its related com-
plications, to the neurosurgery clinic of Children's Hospi-
tal Medical Center in Tehran, Iran from July 2004 to July
2005. This is a referral center that receives most myelom-
eningocele cases born in Tehran and nearby cities. We reg-
istered the sex, age, location of MMC (cervical,
cervicothoracic, thoracic, thoracolumbar, lumbar, lum-
bosacral, and sacral), the time of the prenatal ultrasound
scan (according to the trimester), and the trimester in
which the diagnosis was made (MMC, hydrocephalus or
both) of all patients. The data were analyzed using SPSS
software (SPSS Inc., Chicago, IL).
Results
Among the studied patients, 73 (52.1%) were male, 66
(47.1%) were female and one (0.7%) had an ambiguous
genitalia. The age of the patients ranged from one day to
five years (median 15 days). The most common location
of MMC was thoracolumbar and further distal to it
(91.4%). All, except four patients (2.9%) had at least one
ultrasound scan during the pregnancy. Ultrasound was
done in the first trimester in 55 (39.3%), second trimester
in 103 (73.6%) and third trimester in 120 (85.7%)
patients. The prenatal scan report was normal in 78
patients (57.4%) and for just 17 of them (12.5%) both,
hydrocephalus and MMC, was reported. In 16 patients
(11.8%) only MMC, and in 25 (18.4%) only hydroceph-
alus was detected. MMC was diagnosed in only 33 ultra-
sonographic evaluations (24.3%). We categorized the
lesions into 3 groups according to the MMC locations: cer-
vical/cervicothoracic, thoracic/thoracolumbar and lum-
bar/lumbosacral/sacral. Detection rates were highest for
lesions located in the thoracic/thoracolumbar area (12 of
30; 40%), followed by lesions of the lumbar/lumbosac-
ral/sacral regions (21 of 100; 21%). None of the cervical/
cervicothoracic lesions were detected by prenatal ultra-
sound. The data of prenatal ultrasound scan MMC reports
according to the detection time and level of lesion are
shown in table 1.
Discussion
The incidence of MMC varies from 0.4 to 1.91 per 1000
live births according to the country, culture and socio-eco-
nomic status [5] and the reported incidence in Iran is 1.6
per 1000 [4]. In developed countries due to folic acid sup-
plementation and increased prenatal detection rates fol-
lowed by abortion, the incidence has declined
significantly over the past few decades. Even then it still
affects one in every 2000 live births in the United States
[1].
The significant complications in MMC result from associ-
ated hydrocephalus, the Arnold-Chiari II malformation
and the spinal cord tethering at the site of surgical repair.
Despite early and aggressive intervention, nearly 14% of
neonates born with MMC do not survive more than 5
years. Although most patients have an IQ above 80, only
half are able to live independently as adults [6]. The psy-
chological, social and financial burden on the family and
community is enormous, such that the care of affected
Table 1: Frequency of prenatal ultrasound MMC diagnosis according to the detection time and the level of lesion.
Level of MMC Diagnosed Undiagnosed Total
1st trimester n (%) 2nd trimester n (%) 3rd trimester n (%) n (%) n (%)
Cervical/Cervicothoracic 0 (0) 0 (0) 0 (0) 5 (100) 5 (100)
Thoracic/Thoracolumbar 2 (6.6) 2 (6.6) 8 (26.8) 18 (60) 30 (100)
Lumbar/Lumbosacral/Sacral 0 (0) 8 (8) 13 (13) 79 (79) 100 (100)
Total 2 (1.4) 10 (7.4) 21 (15.5) 102 (75.5) 135*(100)
* One patient was omitted due to double MMC sacs in cervical and sacral regions that could not be placed in this categorization.Reproductive Health 2006, 3:6 http://www.reproductive-health-journal.com/content/3/1/6
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individual costs about $250,000 per person per lifetime in
the United States [6].
As the incidence of this defect is high in Iran [4], it is nec-
essary to take important steps towards primary and sec-
ondary preventive measures. As far as the primary
prevention is concerned the preventive effect of folic acid
on neural tube defects (NTD) is still widely unknown in
Iran and many women are not supplemented with folic
acid before or during the first trimester of pregnancy. Most
of these women receive folic acid after the first or the sec-
ond month of gestation when the neural plate has either
been formed in its natural way into a neural tube or
remained as such. Supplementing folic acid after this
period can be of no help. In Iran, there is no national
health policy for folic acid supplementation to women in
the child-bearing age, before planning for pregnancy or
during the first trimester. Antenatal ultrasound has been
reported to be an effective tool for detecting NTDs, and in
Iran it is usually performed for assessing fetal biometric
parameters in most pregnancies. Moreover, major struc-
tural abnormalities can be detected by ultrasound exami-
nation, depending on the time of ultrasound scan. The
recommended time and the number of ultrasound scans
vary according to the national consensus, the experience
of health care providers and other related factors. In the
United Kingdom, from the early 1990's pregnant women
are offered serum α-fetoprotein screening for NTD's at
15–18 weeks of gestation and an ultrasound scan at 18–
22 weeks [3]. Likewise, in France, three ultrasound scans
are usually performed around the 12th, 22nd and the 32nd
week of gestation. In the USA, there is no policy about the
number and timing of ultrasound scans and it is mainly
performed for selected patients, such as those with a pos-
itive family history, clinical symptoms or abnormal
maternal serum α-fetoprotein levels [2]. This practice is
somewhat similar to the one currently in place in Iran.
Whatever policy is present, screening with the help of
ultrasound scan is mainly based on two-dimensional
imaging techniques. Doppler and the three-dimensional
ultrasound scans have not clearly demonstrated their
superiority over the conventional two-dimensional ultra-
sound scan; however they may be useful to pinpoint the
anatomy of the complex lesions [2]. The first trimester
conventional ultrasound can detect the majority of cases
of anencephaly, but a significant proportion of abnormal-
ities such as the MMC is only detected in the second tri-
mester. However, recent reports show that a transvaginal
scan in the first trimester for high-risk population can be
of a greater help [7].
There is a long debate regarding which screening modality
should be used as both the serum α-fetoprotein and ultra-
sound are effective, but some recent studies have shown
that there is a trend towards increased use of first and sec-
ond trimester ultrasound scan in a number of developing
countries [7,8]. The sensitivity differs, where the gestation,
time allowed for scan, quality of equipment, training and
skills of operators may affect the prenatal detection rates
as well as different scan and biochemical screening poli-
cies.
Less severe forms of MMC are compatible with life and
early ultrasound diagnosis allows for decision making ear-
lier in pregnancy [3]. Ultrasound in the second trimester
can detect MMC by using the standard biparietal cross-
sectional view of the fetal head and visualizing the lateral
ventricles: the "lemon sign" denotes the scalloping frontal
bones, predictive of spina bifida, further, the "banana
sign" refers to the abnormally shaped midbrain and an
elongated cerebellum in the Arnold-Chiari malformation.
Among fetuses with MMC, the "lemon sign" can be
detected in 80% and the "banana sign" in 93% of cases.
Thus, prenatal finding of an abnormal posterior fossa or
ventriculomegaly should prompt the sonographist to rule
out an accompanying spinal deformation and serial scans
of the fetal spine, performed in a longitudinal and trans-
versal axis as well as parallel to the skin, should be done.
An abnormal position of the fetal foot or an enlarged
bladder can be the consequence of severe functional
impairments, but their absence cannot be considered as
reassuring [5].
Obesity, oligohydramnios or poor fetal position can cause
an inability to obtain adequate images. At the same time
ultra-fast Magnetic Resonance Imaging (MRI) provides
detailed, reproducible images of fetal anomalies but it is
difficult to adequately evaluate the fetus before 18 weeks
of gestation because of its small size. MRI has been helpful
to augment the ultrasound diagnosis of CNS abnormali-
ties and is less affected by the above-mentioned pitfalls of
ultrasound [9].
Other studies have reported different MMC detection
rates. In a large study across Europe, the range varied from
33% to 100% in different countries, with a mean of 68%
[3]. Our detection rate (24.3%) was much lower, which
can be due to lack of a national screening policy for MMC,
not paying enough attention to find MMC in routine
ultrasound and low resolution ultrasound equipment. We
suggest referring all pregnant women at 20–22 weeks of
gestation to a well equipped ultrasound center with qual-
ified operators for a formal search of fetal anomalies,
including MMC.
Conclusion
Due to the lack of a national policy for prenatal ultra-
sound screening in Iran, the ultrasound scans performed
during pregnancy are either according to the protocol ofPublish with BioMed Central    and   every 
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the health center, the health care provider or solely on the
woman's request. Measurement of maternal serum α-feto-
protein at 15–18 weeks and a detailed high resolution
ultrasound scan at 20–22 weeks of gestation can help in
the early detection of MMC. The law in Iran allows abor-
tion only up-to the fourth month of gestation. As it is dif-
ficult to diagnose MMC in the first trimester, the delay for
pregnancy termination in Iran for this rather prevalent
anomaly should be increased up to the sixth month of
gestation.
Abbreviations
CNS: Central Nervous System
MMC: Myelomeningocele
NTD: Neural Tube Defect
MRI: Magnetic Resonance Imaging
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
The authors contributed equally to this work.
References
1. Cohen AR, Robinson S: Myelomeningocele and myelo-
cystocele.  In Youmans Neurological surgery Volume 2. 5th edition.
Edited by: Winn HR. Philadelphia: Saunders; 2003:3215-3228. 
2. Aubry MC, Aubry JP, Dommergues M: Sonographic prenatal diag-
nosis of central nervous system abnormalities.  Child Nerv Syst
2003, 19:391-402.
3. Boyd PA, Wellesley DG, De Walle HEK, Tenconi R, Garcia-Minaur S,
Zandwijken GR, Stoll C, Clementi M: Evaluation of the prenatal
diagnosis of neural tube defects by fetal ultrasonographic
examination in different centers across Europe.  J of Medical
Screening 2000, 7:169-174.
4. Ketabchi SE, Ghodsi SM, Nejat F: Incidence of gross nervous sys-
tem anomalies in newborns at two obstetric centers in
Tehran.  J of medical council of I.R.Iran 2001, 18(4):277-281.
5. Cohen AR, Robinson S: Early management of Myelomenin-
gocele.  In Pediatric neurosurgery, surgery of the developing nervous sys-
tem 4th edition. Edited by: MClone DG. Philadelphia: Saunders;
2001:241-260. 
6. Adzick NS, Walsh DS: Myelomeningoclele: prenatal diagnosis,
pathophysiology and management.  Seminars in Pediatric Surgery
2003, 12(3):168-174.
7. Becker R, Wegner RD: Detailed screening for fetal anomalies
and cardiac defects at the 11–13-week scan.  Ultrasound Obstet
Gynecol 2006, 27:613-618.
8. Chitty LYNS, Pandya P: Ultrasound screening for fetal abnor-
malities in the first trimester.  Prenatal Diagnosis 1997,
17(13):1269-1281.
9. Hubbard AM: Ultra fast fetal MRI and prenatal diagnosis.  Sem-
inars in Pediatric Surgery 2003, 12(3):143-153.